Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal ...

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

Today, Thermo Fisher has a leading portfolio of offerings in cell culture media and single-use technologies. Solventum’s innovative filtration portfolio broadens Thermo Fisher’s capabilities ...

Veeva Systems, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing ... The department is focused on offering upstream cell culture, downstream purification ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum  to acquire Solventum’s ...